Count | |
| 4 | |
| 3 | |
| 1 | |
| 1 | |
Vinblastine/*analogs & derivatives/pharmacokinetics/pharmacology | 1 |
| 3 | |
| 1 | |
| 6 | |
| 7 | |
| 3 | |
| 37 | |
| 6 | |
| 1 | |
| 41 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 6 | |
| 6 | |
Vinblastine/adverse effects/*analogs & derivatives/pharmacology | 1 |
Vinblastine/adverse effects/analogs & derivatives/*therapeutic use | 1 |
Vinblastine/adverse effects/analogs & derivatives/therapeutic use | 1 |
Vinblastine/administration & dosage/adverse effects/*analogs & derivative | 1 |
Vinblastine/administration & dosage/adverse effects/analogs & derivatives | 1 |
| 1 | |
| 36 | |
| 1 | |
| 43 | |
| 1 | |
| 3 | |
| 6 | |
| 4 | |
| 2 | |
| 4 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 10 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 4 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 11 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 4 | |
| 1 | |
| 2 | |